HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2229584Generated: November 2, 2026
4-Methylmorpholine → CBz-D-phenylglycine 4-[l-(Boc)piperidin-4-yl]piperidinamide
https://huagongshe.com/reaction/2229584
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | Isobutyl chloroformate | HCID 62365 | — |
| Reactant | (R)-(((Phenylmethoxy)carbonyl)amino)phenylacetic acid | HCID 87183 | — |
| Reactant | 4,4'-Bipiperidine, 1-boc protected | HCID 11747599 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | CBz-D-phenylglycine 4-[l-(Boc)piperidin-4-yl]piperidinamide | HCID 131722771 | 121.1% |
Reaction Steps
To a solution of CBz-D-phenylglycine (877 mg, 3.1 mmol) in anhydrous THF (40 ml) at −25° C. was added N-methylmorpholine (336 μl, 3.1 mmol) and isobutyl chloroformate (419 μl, 3.1 mmol). The resulting suspension was left to stir for 5 min at this temperature and then the t-Butyl 4-(piperidin-4-yl)piperidine-1-carboxylate (825 mg, 3.1 mmol) in anhydrous THF (5 ml) was added in one portion at −25° C. and the reaction mixture allowed to warm to room temperature over 1 hour. The N-methylmorpholine hydrochloride was filtered off and the THF removed under vacuo. The resulting solid was treated with TFA/DCM (20 ml, 1:1) and the reaction mixture left to stir for 2 hours. The organics were removed under vacuo, the residue dissolved in ethyl acetate (100 ml), washed with aq. sodium bicarbonate solution, brine, dried and concentrated to yield the title compound as a clear oil (1.12 g, 84% over two steps).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06420438B1 |
|---|
| Source dataset | uspto-grants-2002_07 |
|---|
| ORD ID | ord-c804f129be314174bd8d191b638dd478 |
|---|
| Source note | uspto-grants-2002_07 |
|---|